icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Trying to Catch the Crest of the Cannabis Wave This Summer

By J.J. McCoy, Senior Managing Editor for New Frontier Data Tracking trends in the burgeoning U.S. cannabis industry can be a dizzyingly ambitious activity. There are now 30 states plus the District of Columbia (D.C.) which have legalized cannabis for medical use, and 9 states plus D.C. which have legalized cannabis for adult-use. Another handful of […]
Read more

U.S. Total CBD Market By Sector (in Millions)

  The FDA last week approved UK-based GW Pharmaceuticals’ Epidiolex, a “pure plant-derived CBD” extract shown to drastically reduce seizures in children with epileptic syndromes. Marking the FDA’s first-ever approval of a cannabis-derived pharmaceutical product, the DEA has 90 days (until September 23) to schedule Epidiolex, a landmark decision being carefully scrutinized by the industry at [...]
Read more

Additional Revenues from Potential State Legalization

  More than a dozen states are expected pass new cannabis legalization measures before 2025. Of them, four are expected to open medical markets, while nine may embrace adult use. The new markets may add another $21.4 billion (a 22% increase) in total revenue to the U.S. legal market between 2021 and 2025. The revenue increase […]
Read more

Top 10 Publicly Traded U.S. Cannabis Companies by Market Cap

  $23.9 billion The top 10 publicly traded U.S. cannabis companies are valued at $8.2 billion collectively, (CAD 23.9 billion), as illustrated here last week. Scotts Miracle-Gro drives most of the value of the top American companies, the $4.7 billion company already established as a leading lawn-and-garden supplier before investing heavily in cannabis assets, the most recent being […]
Read more

U.S. Legal vs Illicit Cannabis Market Demand

  Cannabis use rates will continue to rise as legalized medical and adult-use programs spread across the U.S. and become normalized. Rising usage rates coupled with natural population growth will result in a growing illicit market. However, the rate of growth for an illicit market will be tempered (roughly 2% average per year through 2025) due […]
Read more

Increase in U.S. Cannabis Consumption Rate

  Since 2011, more than 7.5 million adults have joined the ranks of now 22.4 million regular cannabis users. New Frontier Data’s research suggests that the increase reflects a shift: Infrequent users are consuming more regularly, rather than new consumers suddenly becoming regular users. The growing base of regular consumers highlights the need to understand […]
Read more

2 Million Medical Patients Impacted?

  The Rohrabacher-Blumenauer Amendment works to protect medical cannabis programs in 29 states and the District of Columbia. The states most affected by a non-renewal of this amendment would be California, Michigan, and Arizona, as they comprise 70% of the nearly 2 million registered U.S. cannabis patients in the U.S. Support for medical cannabis is […]
Read more

The LGBT Community – A Potent Constituency Among Cannabis Consumers

The LGBT Community – A Potent Constituency Among Cannabis Consumers According to the Movement Advancement Project (MAP), 4.3% of adults in Colorado identify as LGBT, yet the same demographic represents 8% of the state’s past-month cannabis users. That rate of engagement suggests the LGBT community as a significant if largely untapped business opportunity to develop […]
Read more

Strong Growth, Limited Access to Banking Fuels Private Cannabis Investment

Strong Growth, Limited Access to Banking Fuels Private Cannabis Investment  Between Q1 2016 and Q1 2017, Viridian Capital Advisors tracked 439 cannabis investment deals, totaling $1.92 billion capital raised across 12 segments of the industry. The top performing sector – cultivation & retail – saw nearly half a billion dollars in new investment to meet […]
Read more

Following Strong Growth, Spicer’s Comments Spark Big Decline in Cannabis Stocks

Threatening Signals from White House Spark Pullback in Cannabis Stocks In 2016, the Viridian Cannabis Stock Index grew 236%, partly fueled by opportunities created by the ten new states that passed medical and adult use laws last November. The index declined briefly after the election due to investor concerns about how the Trump Administration’s cannabis […]
Read more